Sensitive ASX Announcement

Ethics Approval Received for NUZ-001 Oral Liquid P1 Study

Published: 13/05/26, 09:19am (AEST)2 pages
Neurizon Therapeutics
NUZ:ASXHealthcare

Recent NUZ Announcements

Price Sensitive only